The mumps vaccine (Jeryl-Lynn strain) was licensed in 1967 and recommended for routine use in 1977. The mumps vaccine strain produces a mild, non-communicable infection. Post-licensure studies determined that one dose of measles-mumps-rubella (MMR) vaccine is about 78% effective in disease prevention, while two doses are about 88% effective.